Literature DB >> 7119089

Antibody-dependent cellular cytotoxicity to allogeneic but not autologous erythroblasts in vitro.

S B Krantz, E N Dessypris.   

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) is a very sensitive mechanism for immune injury of target cells, which utilizes extremely low concentrations of antibody. We have developed a method for demonstrating this type of cytotoxicity to normal human erythroblasts. The latter were enriched 3- to 4-fold and were then labeled with 59Fe. Blood lymphocytes from the same donor were enriched to 93% and were added as effector cells at a 60:1 ratio to the target cells. After 4 hr at 37 degrees C, as 5- to 10-fold increase in the release of 59Fe occurred when the plasma or IgG from patients with pure red-cell aplasia was present. This activity was not present when the effector cells were absent. However, this activity was found in the remission plasmas of patients and was not found when autologous erythroblasts were used. These studies demonstrate a method for detecting ADCC to allogeneic normal human erythroblasts. This ADCC does not appear to be related to the disease since a similar autoimmune activity to the patients' own erythroid cells was not detected. Further studies are suggested using other effector cells in this system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119089     DOI: 10.1007/bf00915225

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

1.  A new method for preparing buffy coat-poor blood.

Authors:  T J GREENWALT; M GAJEWSKI; J L McKENNA
Journal:  Transfusion       Date:  1962 Jul-Aug       Impact factor: 3.157

2.  Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings.

Authors:  R P Warren; R Storb; P L Weiden; P J Su; E D Thomas
Journal:  Transplant Proc       Date:  1978-06       Impact factor: 1.066

3.  ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.

Authors:  D L Nelson; D G Poplack; B J Holiman; P A Henkart
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

4.  Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosus: reversal with corticosteroid therapy.

Authors:  J Cavalcant; R K Shadduck; A Winkelstein; Z Zeigler; H Mendelow
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

5.  Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children.

Authors:  E N Dessypris; S B Krantz; J S Roloff; J N Lukens
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

6.  Human renal allograft rejection is predicted by serial determinations of antibody-dependent cellular cytotoxicity.

Authors:  L J Dumble; I M MacDonald; P Kincaid-Smith
Journal:  Transplantation       Date:  1980       Impact factor: 4.939

7.  Metal cation requirements for phytohemagglutinin-induced transformation of human peripheral blood lymphocytes.

Authors:  R H Alford
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

8.  Human lymphocyte antibody-dependent cell-mediated cytotoxicity (ADCC) toward human red blood cells.

Authors:  G M Shaw; P C Levy; A F LoBuglio
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

9.  Detection of cytotoxic antibody to erythroblasts.

Authors:  S D Zaentz; J A Luna; A S Baker; S B Krantz
Journal:  J Lab Clin Med       Date:  1977-04

10.  Immune suppression of erythropoiesis in transient erythroblastopenia of childhood.

Authors:  H M Koenig; A L Lightsey; D P Nelson; L K Diamond
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.